Retinal venular vasculature may predict initial treatment response to intravitreal therapy
Denmark: A research article published in Acta Ophthalmologica, a study has demonstrated that retinal venular vasculature may predict the initial treatment response to intravitreal therapy. If the visual and functional prognosis of nAMD patients can be categorized before initiating treatment, then it is possible to provide a personalized treatment regimen.
Prediction of the early treatment response is crucial in neovascular age-related macular degeneration (nAMD).
Researchers in the present study tested whether non-invasive measurements of the retinal vascular structure predict initial intravitreal treatment outcomes.
They included 58 eyes (58 patients) with treatment-naïve nAMD. Using Singapore I Vessel Assessment, they measured advanced markers of the retinal vascular structure before starting intravitreal treatment, which included three monthly injections of aflibercept.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.